PF 07985819
Alternative Names: pdmFlu vaccine - Pfizer; PF-07985819; Quadrivalent influenza vaccine - PfizerLatest Information Update: 15 Jan 2024
Price :
$50 *
At a glance
- Originator Pfizer
- Class Antivirals; Influenza virus vaccines; RNA vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase I Influenza virus infections
Most Recent Events
- 27 Dec 2023 Preclinical trials in Influenza virus infections (Prevention) in USA (IM)
- 13 Dec 2023 Phase-I clinical trials in Influenza virus infections (Prevention) in USA (IM) (NCT06179446)
- 13 Dec 2023 Pfizer plans a phase I trial for Influenza virus infection in the US (NCT06179446)